Merck & Co’s CEO Kenneth Frazier has said the pharma industry must take on the challenge of its poor public perception. In an interview with Yahoo Finance, Frazier defended the industry’s ...

Merck & Co CEO Ken Frazier said that he is also looking to do some deals, admitting that several had fallen through because valuations had been too high and competition too intense. “Broadly ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other cheap high dividend stocks. According to Deutsche Bank Wealth Management, the global ...

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Get today’s market-moving stories from the CEO perspective. Each weekday, Fortune's Diane Brady and our world-class newsroom offer perspective, as well as insights from fellow CEOs and industry ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

We talk with a former DOJ environmental enforcement lawyer who says Trump's funding pauses and cuts to staff at climate and environment programs will have a lasting impact.